Author

T. Kuopio

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Approach:statistical model· 2 Approach:biophysical modeling· 1 Research Focus:cell type annotation· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

M. Ahtiainen· 2 shared A. Jawahar-Deen· 1 shared A. Lepistö· 1 shared A.-L. Levonen· 1 shared E. Dimova· 1 shared E. K. Laakkonen· 1 shared E. Sillanpää· 1 shared E.-M. Talvitie· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

M. Ahtiainen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pan-cancer scale screening reveals NRF2 associated immunoevasive characteristics in non-small cell lung cancer and squamous malignancies

J. Harkonen, P. Polonen, A. Jawahar-Deen, I. Selvarajan, H.-R. Teppo, E. Dimova, T. Kietzmann, M. Ahtiainen, T. Eklund, T. Kuopio, E.-M. Talvitie, P. Taimen, M. Kallajoki, M. U. Kaikkonen, M. Heinaniemi, A.-L. Levonen

This paper identifies NRF2-associated immunoevasive features in NSCLC and squamous cancers, linking NRF2 activity to immune-cold phenotypes and potential biomarkers for immune checkpoint response.

bioRxiv · May 15, 2022 · PreprintCancer Biology

Systemic circulating microRNA landscape in Lynch syndrome

T. Sievänen, T.-M. Korhonen, T. Jokela, M. Ahtiainen, L. Lahtinen, T. Kuopio, A. Lepistö, E. Sillanpää, J.-P. Mecklin, T. T. Seppälä, E. K. Laakkonen

This study identifies circulating miRNA signatures in Lynch syndrome carriers that distinguish them from non-carriers but not from cancer patients, suggesting potential for monitoring oncogenic stress in cancer-free individuals.

bioRxiv · Mar 10, 2022Cancer Biology